Aspire Biopharma Warrant
ASBPW
30 hedge funds and large institutions have $604K invested in Aspire Biopharma Warrant in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 6 closing their positions.
9% less funds holding
Funds holding: 33 → 30 (-3)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
86% less capital invested
Capital invested by funds: $4.47M → $604K (-$3.87M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Context Capital Management
Lajolla,
California
|
+$8.33K |
| 2 |
CS
Clear Street
New York
|
+$4.07K |
| 3 |
BOCH
Blue Owl Capital Holdings
New York
|
+$2.38K |
| 4 |
CAC
Cowen and Company
New York
|
+$1.37K |
| 5 |
HF
HRT Financial
New York
|
+$675 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$12.5K |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
-$5.95K |
| 3 |
FSI
Flow State Investments
Chicago,
Illinois
|
-$5.1K |
| 4 |
KL
KIM LLC
Wichita,
Kansas
|
-$4.49K |
| 5 |
EAM
Exos Asset Management
New York
|
-$4.11K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Adage Capital Partners
Boston,
Massachusetts
| $1.05K | – | – | – |
|
|
MTCM
27
Mint Tower Capital Management
Amsterdam,
Netherlands
| $1K | – | – | – |
|
|
PMAM
28
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
MC
29
Meteora Capital
Boca Raton,
Florida
| $888 | -$190 | -4,000 | -16% |
|
|
PI
30
PEAK6 Investments
Chicago,
Illinois
| $529 | – | – | – |
|
|
EAM
31
Exos Asset Management
New York
| – | -$4.11K | -137,000 | Closed |
|
|
LP
32
LMR Partners
London,
United Kingdom
| – | -$5.95K | -125,000 | Closed |
|
|
FSI
33
Flow State Investments
Chicago,
Illinois
| – | -$5.1K | -113,498 | Closed |
|
|
KL
34
KIM LLC
Wichita,
Kansas
| – | -$4.49K | -100,000 | Closed |
|
|
FPA
35
First Pacific Advisors
El Segundo,
California
| – | -$783 | -28,482 | Closed |
|
|
HF
36
HRT Financial
New York
| – | +$675 | +14,183 | New |
|
ASBPW Hedge Fund Activity: Q3 2024 in Review
30 of the 6,967 institutional investors tracked by Wall St. Rank reported a position in Aspire Biopharma Warrant (ASBPW) for Q3 2024, worth a combined $604K — down 86% from $4.47M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ASBPW and 4 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Context Capital Management, opening a new position worth an estimated $8.33K. The largest seller was Periscope Capital, cutting an estimated $12.5K.
- 30 institutional investors held Aspire Biopharma Warrant (ASBPW) as of Q3 2024, down from 33 in Q2 2024.
- Funds reported $604K of Aspire Biopharma Warrant stock for Q3 2024, down 86% quarter-over-quarter.
- 4 funds opened new Aspire Biopharma Warrant positions in Q3 2024 and 6 closed out, a net change of -2 holders.
- The largest Aspire Biopharma Warrant buyer in Q3 2024 was Context Capital Management, an estimated $8.33K added.
- The largest Aspire Biopharma Warrant seller in Q3 2024 was Periscope Capital, an estimated $12.5K sold.
Based on aggregated 13F filings for Q3 2024.